Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...

Share on Pinterest Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The FDA expanded its approval ...

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65. The announcement Monday from ...

The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...

INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...

On October 17, 2015, a new drug, Addyi (ADD-ee, flibanserin), becomes available to treat the 10 percent of women whose low libido, or “female hypoactive sexual desire disorder,” causes significant ...